Tumor Ablation Market 2018; Reaches to USD 0.86 Billion Registering a CAGR of ~13.15 by 2023 | AngioDynamics Inc, Galil Medical Inc, SonaCare Medical, Boston Scientific, EDAP TMS S.A, HealthTronics Inc, Medtronic, NeuWave Medical and MISONIX Inc.

Tumor Ablation Market By Technology, Treatment And Application- Global Industry Analysis And Forecast To 2023.

The Tumor Ablation Market was worth USD 0.28 billion in 2014 and is expected to reach approximately USD 0.86 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 13.15% during the forecast period.

Competitive Insights:

The leading players in the market are AngioDynamics Inc, Galil Medical Inc, SonaCare Medical, Boston Scientific, EDAP TMS S.A, HealthTronics Inc, Medtronic, NeuWave Medical and MISONIX Inc. These industry players have implemented different methodologies to support their position in the market. For example, collaborations, new product launches, mergers and acquisitions, technological advancements are the most well-known activities in this industry.

Sample Copy of This Report: https://www.crystalmarketresearch.com/report-sample/HC06854 .

Industry Updates:

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally.

Boston Scientific Corporation announced the launch of the GUIDE™ XT System for visualization of Deep Brain Stimulation (DBS) in Europe. The GUIDE XT System is the first DBS visualization system built for directionality that utilizes patient specific anatomy and stimulation field modeling.

Misonix, Inc. demonstrated for the first time publicly its next generation platform technology, neXus. neXus combines all the features of Misonix’s existing solutions, including BoneScalpel, SonicOne and Sonastar, into one fully integrated platform.

Industry Outlook and Trend Analysis:

Expanding pervasiveness of cancer is the main consideration contributing for the development of the market. On the basis of the insights published by World Health Organization (WHO), around 13% of the general population suffer from cancer around the world. Furthermore, there is 70.0% ascent in cancer cases expected throughout the following couple of decades. Hence, in excess of 100 cancer composes need tumour ablation in this manner boosting market development over the conjecture time frame. Technological progressions in the field of thermal ablation technologies are expected to fuel market development. The fast ascent in maturing populace is anticipated to increase.

Technology Outlook and Trend Analysis:

Radiofrequency tumor ablation technology held considerable share in 2015. Radiofrequency ablation uses of imaging devices and needle electrode probe to pierce through skin. High recurrence currents are gone through electrode for creating heat in order to decimate tumor cells. These electric currents create sound waves; these waves at that point produce warm responding target cell particle. Increasing application of this innovation in solid tumor removal everywhere throughout the body and its specificity contributed its development.

Treatment Outlook and Trend Analysis:

Surgical ablation fragment held significant share of 42.1% of every 2015. Expanded pervasiveness of cancers such as liver disease and breast cancer, which require open surgical methods, added to development of surgical procedures. Nonetheless, percutaneous procedures are anticipated to reflect lucrative development over the estimate time frame. Rising interest for minimally invasive surgeries is high-affect rendering factor adding to their development. These methods offer quicker recovery, diminished scarring, and expanded security.

Tumor Ablation Market, By Technology:

Microwave ablation
Cryoablation
Radiofrequency ablation
Other ablation technologies

Tumor Ablation Market, By Treatment:

Surgical tumor ablation
Laparoscopic tumor ablation
Percutaneous tumor ablation

Tumor Ablation Market, By Application:

Liver cancer
Breast cancer
Lung cancer
Prostate cancer
Other cancers

Browse Complete Report with ToC: https://www.crystalmarketresearch.com/report/tumor-ablation-market .

Application Outlook and Trend Analysis:

Liver cancer represented biggest shares in 2015. Liver cancer is most common in males as opposed to females, and rising rate of bile duct cancer and also primary liver cancer brought about their dominion. Lung cancer has been expected to develop with the most astounding CAGR amid the conjecture time frame. The prevalence of lung cancer is rising, especially cancer types such as Non-Small Cell Lung Cancer (NSCLC).

Tumor Ablation Market, By Region:

North America - U.S, Canada, Mexico

Europe - Germany, France, UK, Italy, Spain, Rest of Europe

Asia-Pacific - Japan, China, Australia, India, South Korea, Rest of Asia Pacific

Rest of the World - Brazil, South Africa, Saudi Arabia, United Arab Emirates, Others

Regional Outlook and Trend Analysis:

North America ruled the general tumor ablation market with more than 32.0% share in 2015. Main factors adding to development of this district incorporate support of the government for quality healthcare, availability of reimbursement, high purchasing power parity, and expanding predominance of growths in the U.S. also, Canada. In expansion, accuracy prescription activity is detailing the custom fitted procedures on exceptional qualities of diseases.

Tumor Ablation Market, ToC:

Chapter 1. Introduction

Chapter 2. Executive Summary

Chapter 3. Market Overview
...
Chapter 9. Company Profiles

9.1. Medtronic Plc.
9.1.1.Business Overview
9.1.2.Product Portfolio
9.1.3.Strategic Developments
9.1.4.Sales, Revenue and Market Share

9.2. Angiodynamics
9.2.1.Business Overvie
9.2.2.Product Portfolio
9.2.3.Strategic Developments
9.2.4.Sales, Revenue and Market Share

9.3. Mermaid Medical
9.3.1.Business Overview
9.3.2.Product Portfolio
9.3.3.Strategic Developments
9.3.4.Sales, Revenue and Market Share

9.4. HealthTronics
9.4.1.Business Overview
9.4.2.Product Portfolio
9.4.3.Strategic Developments
9.4.4.Sales, Revenue and Market Share

9.5. Galil Medical Inc.
9.5.1.Business Overview
9.5.2.Product Portfolio
9.5.3.Strategic Developments
9.5.4.Sales, Revenue and Market Share

9.6. EDAP TMS S.A.
...

Discuss Our Expert Team: https://www.crystalmarketresearch.com/send-an-enquiry/HC06854 .

Reason to Buy -

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the Tumor Ablation market, thereby allowing players to develop effective long term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

Continued…

About Crystal Market Research:

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customised research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com

This release was published on openPR.